Affluent Medical
Develops minimally invasive implants for structural heart disease and urology.
AFME | PA
Overview
Corporate Details
- ISIN(s):
- FR0013333077 (+3 more)
- LEI:
- 969500N30CO4B5N2GN67
- Country:
- France
- Address:
- 320 AVENUE ARCHIMEDE, 13290 AIX-EN-PROVENCE
- Website:
- https://www.affluentmedical.com
- Sector:
- Manufacturing
Description
Affluent Medical is a clinical-stage medical technology company that develops innovative, minimally invasive implants designed to restore essential physiological functions. The company's activities are concentrated in two primary therapeutic areas: structural heart disease and urology. It specifically addresses severe mitral valve insufficiency and urinary incontinence. The product pipeline, currently in clinical development, features three key devices: Kalios™, an adjustable annuloplasty ring for mitral valve repair; Epygon™, a biomimetic mitral valve for replacement procedures; and Artus™, an electronic artificial urinary sphincter for treating urinary incontinence. Affluent Medical's technologies are engineered to be adjustable and biomimetic, allowing for implantation via minimally invasive surgery and adaptation to both the patient's anatomy and the progression of their pathology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-09-22 17:45 |
Affluent Medical : Résultats financiers du premier semestre 2021 et principales…
|
French | 314.6 KB | ||
| 2021-09-22 17:45 |
Affluent Medical : Rapport Financier Semestriel au 30 juin 2021.
|
French | 1.1 MB | ||
| 2021-09-22 17:45 |
Affluent Medical : Half-year financial report at 30 june 2021.
|
English | 1.1 MB | ||
| 2021-09-16 17:45 |
Affluent Medical : Succès du premier ajustement post-opératoire de l'anneau mit…
|
French | 191.5 KB | ||
| 2021-09-16 17:45 |
Affluent Medical : Successful first post-operative adjustment of KaliosTM mitra…
|
English | 168.7 KB | ||
| 2021-08-30 18:23 |
Affluent Medical : Apport complémentaire au contrat de liquidité
|
French | 120.8 KB | ||
| 2021-08-20 17:45 |
Affluent Medical : Nombre d'actions composant le capital social et nombre total…
|
French | 382.4 KB | ||
| 2021-07-13 17:51 |
Affluent Medical :Calendrier de communication financière du second semestre 2021
|
French | 148.9 KB | ||
| 2021-07-13 17:51 |
Affluent Medical : Financial communication schedule for the second half of 2021
|
English | 102.6 KB | ||
| 2021-07-09 17:45 |
Affluent Medical : Bilan semestriel du contrat de liquidité avec Kepler Cheuvre…
|
French | 134.8 KB | ||
| 2021-07-09 17:45 |
Affluent Medical : Nombre d'actions composant le capital social et nombre total…
|
French | 184.9 KB | ||
| 2021-06-14 08:30 |
Affluent Medical : Liquidity contract implementation with Kepler Cheuvreux.
|
English | 61.3 KB | ||
| 2021-06-14 08:30 |
Affluent Medical : Mise en œuvre d'un contrat de liquidité avec Kepler Cheuvreu…
|
French | 146.6 KB | ||
| 2021-06-09 20:12 |
Affluent Medical announces the success of its initial public offering on the Eu…
|
English | 335.9 KB | ||
| 2021-06-09 20:12 |
Affluent Medical annonce le succès de son introduction en bourse sur le marché …
|
French | 341.7 KB |
Automate Your Workflow. Get a real-time feed of all Affluent Medical filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Affluent Medical
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Affluent Medical via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-16 | N/A | Other | Other | 2,479,411 | 3,421,587.18 EUR |
| 2024-01-29 | N/A | Other | Other | 1,419,871 | 2,214,998.76 EUR |
| 2023-03-06 | N/A | Other | Other | 6,363,034 | 8,399,204.88 EUR |
| 2023-03-06 | N/A | Other | Other | 6,363,034 | 190,891.02 EUR |
Peer Companies
